Edit |   |
---|---|
Antigenic Specificity | CD257, Human (Belimumab biosimilar) |
Clone | Belimumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 lambda |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | FCM, IP, ELISA, Neut, FuncS, IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD257 Recombinant Antibody (Belimumab). Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), also known as B-lymphocyte stimulator (BLyS). It is approved in the United States, Canada, and the European Union to treat systemic lupus erythematosus (SLE). |
Immunogen | n/a |
Other Names | Anti-CD257 Recombinant Antibody, Research Grade Belimumab, Anti-Human CD257 Recombinant Antibody(Belimumab), LymphoStat-B, hBlySmAb-1.1, Antibody Drug Analogues, Monoclonal Antibody, YR1176, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 356547-88-1 |
Catalog # | YR1176 |
Price | please inquire |
Order / More Info | CD257, Human (Belimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |